Timothy Daley
Stock Analyst at Wells Fargo
(3.18)
# 1,149
Out of 4,479 analysts
58
Total ratings
51.52%
Success rate
0.4%
Average return
Main Sectors:
21 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $45 | $40.70 | +11.35% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $24.76 | -19.22% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $102.01 | -6.87% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $61.64 | +16.81% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $125.78 | +15.28% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,357.07 | -4.21% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $284.49 | +0.18% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $240.41 | +2.74% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $201.48 | +36.49% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $202.73 | +33.18% | 3 | Aug 14, 2023 | |
| NEOG Neogen | Maintains: Overweight | $22 → $28 | $15.13 | +85.06% | 2 | Aug 14, 2023 | |
| STVN Stevanato Group | Maintains: Overweight | $30 → $35 | $18.00 | +94.44% | 6 | Jul 31, 2023 | |
| TMO Thermo Fisher | Maintains: Underweight | $505 → $520 | $533.93 | -2.61% | 3 | Jul 28, 2023 | |
| NOTV Inotiv | Initiates: Overweight | $9 | $1.61 | +459.01% | 1 | Jul 20, 2023 | |
| RGEN Repligen | Initiates: Overweight | $185 | $120.14 | +53.99% | 1 | Jul 20, 2023 | |
| HOLX Hologic | Maintains: Equal-Weight | $80 → $85 | $73.53 | +15.60% | 3 | May 2, 2023 | |
| IQV IQVIA Holdings | Maintains: Equal-Weight | $235 → $220 | $207.47 | +6.04% | 2 | May 1, 2023 | |
| ICLR ICON PLC | Maintains: Equal-Weight | $245 → $220 | $318.30 | -30.88% | 2 | May 1, 2023 | |
| AVTR Avantor | Maintains: Overweight | $25 → $28 | $20.58 | +36.05% | 4 | Feb 8, 2023 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $135 → $140 | $136.64 | +2.46% | 2 | Feb 3, 2023 | |
| TECH Bio-Techne | Upgrades: Equal-Weight | $90 | $71.24 | +26.33% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $45
Current: $40.70
Upside: +11.35%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $24.76
Upside: -19.22%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $102.01
Upside: -6.87%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $61.64
Upside: +16.81%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $125.78
Upside: +15.28%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,357.07
Upside: -4.21%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $284.49
Upside: +0.18%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $240.41
Upside: +2.74%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $201.48
Upside: +36.49%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $202.73
Upside: +33.18%
Neogen
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $15.13
Upside: +85.06%
Stevanato Group
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $18.00
Upside: +94.44%
Thermo Fisher
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $533.93
Upside: -2.61%
Inotiv
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $1.61
Upside: +459.01%
Repligen
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $120.14
Upside: +53.99%
Hologic
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $73.53
Upside: +15.60%
IQVIA Holdings
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $207.47
Upside: +6.04%
ICON PLC
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $318.30
Upside: -30.88%
Avantor
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $20.58
Upside: +36.05%
Quest Diagnostics
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $136.64
Upside: +2.46%
Bio-Techne
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $71.24
Upside: +26.33%